GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Trees Corp (OTCPK:CANN) » Definitions » Revenue

Trees (CANN) Revenue : $18.14 Mil (TTM As of Dec. 2023)


View and export this data going back to 2011. Start your Free Trial

What is Trees Revenue?

Trees's revenue for the three months ended in Dec. 2023 was $3.82 Mil. Its revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $18.14 Mil. Trees's Revenue per Share for the three months ended in Dec. 2023 was $0.03. Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $0.16.

During the past 12 months, the average Revenue per Share Growth Rate of Trees was 12.30% per year. During the past 3 years, the average Revenue per Share Growth Rate was 48.80% per year. During the past 5 years, the average Revenue per Share Growth Rate was 23.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 13 years, Trees's highest 3-Year average Revenue per Share Growth Rate was 297.90% per year. The lowest was -35.10% per year. And the median was 16.10% per year.


Trees Revenue Historical Data

The historical data trend for Trees's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Trees Revenue Chart

Trees Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.67 2.38 5.93 13.45 18.14

Trees Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.46 5.11 5.10 4.11 3.82

Competitive Comparison of Trees's Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Trees's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Trees's Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Trees's Revenue distribution charts can be found below:

* The bar in red indicates where Trees's Revenue falls into.



Trees Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $18.14 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Trees  (OTCPK:CANN) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Trees Revenue Related Terms

Thank you for viewing the detailed overview of Trees's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Trees (CANN) Business Description

Traded in Other Exchanges
N/A
Address
215 Union Boulevard, Suite 415, Lakewood, CO, USA, 80228
Trees Corp is a vertically-integrated cannabis company and multi-state operator in the United States. It has two segments Retail and Cultivation. It is pursuing a roll-up plan of licensed assets in mature markets while maintaining loyal, local customer bases. TREES owns and operates a light-deprivation greenhouse and a campus of indoor cultivation facilities in Boulder, dispensaries in Englewood, Longmont and Berthoud, Colorado and three dispensaries in Portland, Oregon.
Executives
Carl J Williams director 10 GLENLAKE PARKWAY, NORTH TOWER, ATLANTA GA 30189
Richard C. Travia director 6565 E. EVANS AVENUE, DENVER CO 80224
Allyson Feiler Downing director 3556 W 62ND AVENUE, DENVER CO 80221
Timothy Earl Brown director, 10 percent owner 2301 W 30TH AVENUE, DENVER CO 80211
Diane Jones officer: CHIEF FINANCIAL OFFICER 6565 E. EVANS AVENUE, DENVER CO 80224
Seth Oster director C/O GENERAL CANNABIS CORP, 6565 EAST EVANS AVENUE, DENVER CO 80224
Mark D. Green director C/O GENERAL CANNABIS CORP, 6565 EAST EVANS AVENUE, DENVER CO 80224
Peter Boockvar director C/O MILLER TABAK + CO.,, 331 MADISON AVENUE, NEW YORK NY 10017
John Barker Dalton director, 10 percent owner 6565 E. EVANS AVENUE, DENVER CO 80224
Adam Hershey 10 percent owner 140 RIVERSIDE BOULEVARD, APT 2302, NEW YORK NY 10069
Hershey Strategic Capital, Lp 10 percent owner C/O HERSHEY STRATEGIC CAPITAL GP, LLC, 6 POMPANO ROAD, RUMSON NJ 07760
Hershey Management I, Llc. 10 percent owner 888 7TH AVENUE, 17TH FLOOR, NEW YORK NY 10019
Hershey Strategic Capital Gp, Llc 10 percent owner 888 7TH AVENUE, 17TH FLOOR, NEW YORK NY 10019
Shore Ventures Iii, Lp 10 percent owner C/O HERSHEY MANAGEMENT IV, LLC, 6 POMPANO ROAD, RUMSON NJ 07760
Hershey Management Iv, Llc 10 percent owner 6 POMPANO ROAD, RUMSON NJ 07760